Search results for "corona"

showing 10 items of 3472 documents

The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease.

1998

Abstract —A family history of ischemic events is a major determinant of coronary artery disease (CAD). Plasma levels of plasminogen activator inhibitor 1 (PAI-1) modulate this risk. A deletion/insertion polymorphism within the PAI-1 locus (4G/5G) affects the expression of this gene. We investigated the relationship between the PAI-1 4G/5G polymorphism in 1179 healthy employees of our institution and the occurrence of CAD in their first-degree relatives. A family history of documented ischemic coronary disease was assessed by a modified WHO questionnaire. The PAI-1 4G/5G polymorphism was evaluated by polymerase chain reaction and endonuclease digestion. The group with a first-degree relativ…

AdultMalemedicine.medical_specialtyCoronary DiseaseLocus (genetics)BiologyGastroenterologyMedical RecordsGenetic determinismCohort StudiesCoronary artery diseasechemistry.chemical_compoundRisk FactorsInternal medicinePlasminogen Activator Inhibitor 1medicineHumansFamily historyAlleleAgedGeneticsPolymorphism GeneticChromosome MappingOdds ratioMiddle Agedmedicine.diseasechemistryPlasminogen activator inhibitor-1Regression AnalysisFemaleCardiology and Cardiovascular MedicineBody mass index
researchProduct

Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic …

2020

<b><i>Purpose:</i></b> The coronavirus disease 2019 (COVID-19) pandemic is disrupting urology health-care worldwide. Reduced emergency room visits resulting in adverse outcomes have most recently been reported in pediatrics and cardiology. We aimed to compare patients with emergency room visits for pyelonephritis in 2019 (pre-COVID-19 era) and within the first wave of pandemic in 2020 (COVID-19 era) with regard to the number of visits and severe adverse disease outcomes. <b><i>Methods:</i></b> We performed a retrospective multicentre study comparing characteristics and outcomes of patients with pyelonephritis, excluding patients with hydroneph…

AdultMalemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Adverse outcomesUrologymedicine.medical_treatment030232 urology & nephrologyUrologyComorbiditySide effect03 medical and health sciencesYoung Adult0302 clinical medicineInformation campaignGermanyPandemicmedicineHumansHydronephrosisPandemicsStone diseaseRetrospective StudiesOutcomePyelonephritisbusiness.industrySARS-CoV-2IncidenceCOVID-19Middle Agedmedicine.diseaseNephrectomyHospitalizationCoronavirus030220 oncology & carcinogenesis2019-nCoVCollateral damageFemaleMorbiditybusinessEmergency Service HospitalResearch ArticleUrinary infectionUrologia internationalis
researchProduct

Thromboembolic complications of COVID-19: the combined effect of a pro-coagulant pattern and an endothelial thrombo-inflammatory syndrome.

2020

Coronavirus disease 2019 (COVID-19) is a newly emerging human infectious disease that has quickly become a worldwide threat to health, mainly causing severe acute respiratory syndrome. In addition to the widely described respiratory syndrome, COVID-19 may cause life-treating complications directly or indirectly related to this infection. Among these, thrombotic complications have emerged as an important issue in patients with COVID-19 infection, particularly in patients in intensive care units. Thrombotic complications due to COVID-19 are likely to occur due to a pro-coagulant pattern encountered in some of these patients or to a progressive endothelial thrombo-inflammatory syndrome causing…

AdultMalemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralDiseaseThromboembolic complicationsCOVID-19 CT ComplicationsSevere Acute Respiratory SyndromeCommunicable Diseases EmergingArticle030218 nuclear medicine & medical imagingBrain IschemiaThromboplastin03 medical and health sciences0302 clinical medicineIntensive careCause of DeathThromboembolismmedicineHumansRadiology Nuclear Medicine and imagingIn patientClinical significanceIntensive care medicinePandemicsAgedbusiness.industrypandemicAnticoagulantsCOVID-19General MedicineMiddle AgedstrokeSurvival AnalysisItalyRadiology Nuclear Medicine and imagingInfectious disease (medical specialty)030220 oncology & carcinogenesisFemaleRadiography ThoracicbusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaCoronavirus InfectionsPulmonary EmbolismTomography X-Ray ComputedThrombotic complicationClinical radiology
researchProduct

SARS‐CoV‐2 N‐antigenemia in critically ill adult COVID‐19 patients: Frequency and association with inflammatory and tissue‐damage biomarkers

2021

Abstract The current study aimed at characterizing the dynamics of SARS‐CoV‐2 nucleocapsid (N) antigenemia in a cohort of critically ill adult COVID‐19 patients and assessing its potential association with plasma levels of biomarkers of clinical severity and mortality. Seventy‐three consecutive critically ill COVID‐19 patients (median age, 65 years) were recruited. Serial plasma (n = 340) specimens were collected. A lateral flow immunochromatography assay and reverse‐transcription polymerase chain reaction (RT‐PCR) were used for SARS‐CoV‐2 N protein detection and RNA quantitation and in plasma, respectively. Serum levels of inflammatory and tissue‐damage biomarkers in paired specimens were …

AdultMalemedicine.medical_specialtyCritical IllnessInflammationSARS‐CoV‐2 N‐antigenemiaLogistic regressionSARS‐CoV‐2 RNAemiaGastroenterologyYoung AdultCOVID‐19VirologyInternal medicinemedicineCoronavirus Nucleocapsid ProteinsHumansProspective StudiesAntigens ViralResearch ArticlesAgedAged 80 and overInflammationbiologybusiness.industrySARS-CoV-2virus diseasesCOVID-19Odds ratioMiddle AgedPhosphoproteinsVirologymortalityConfidence intervalinflammation biomarkersFerritinTracheaInfectious DiseasesConcomitantCohortbiology.proteinBiomarker (medicine)RNA ViralFemalemedicine.symptombusinessBiomarkersResearch ArticleJournal of Medical Virology
researchProduct

The distribution of whole blood viscosity, its determinants and relationship with arterial blood pressure in the community: cross-sectional analysis …

2015

Background: Blood viscosity has a role in modulating cardiovascular homeostasis; changes in this parameter have been associated with cardiovascular mortality and morbidity. However, it remains unclear whether these changes are (1) involved in the pathophysiology of disease, (2) an epiphenomenon, or (3) the expression of counterregulatory mechanisms. We report data on the normal values of blood viscosity and its association with cardiovascular risk factors, prevalent cardiovascular disease, and blood pressure in a large population-based cohort study. Methods and results: Viscosity was calculated using validated formulae and its associations were explored in 15,010 participants (mean 55.0, mi…

AdultMalemedicine.medical_specialtyCross-sectional studyBlood viscosityDiseaseCoronary Artery DiseaseRisk AssessmentReference ValuesRisk FactorsInternal medicineGermanymedicinePrevalenceHumansPharmacology (medical)Arterial PressureAgedHeart Failurebusiness.industryWhole blood viscosityRegression analysisMiddle AgedBlood ViscosityHealth SurveysPathophysiologySurgeryBlood pressureCross-Sectional StudiesLogistic ModelsCardiovascular DiseasesCohortCardiologyLinear ModelsFemaleCardiology and Cardiovascular MedicinebusinessTherapeutic advances in cardiovascular disease
researchProduct

Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study)

2018

Sex differences in cardiovascular risk factors, cardiac structure and function, and disease and symptom burden in the common arrhythmia atrial fibrillation (AF) have not been investigated systematically at the population level. Cross-sectional data of 14,796 subjects (age range 35 to 74 years, 50.5% men) from the population-based Gutenberg Health Study were examined to show the distribution of cardiovascular risk factors by AF status and sex, and to determine sex-specific predictors for AF. The prevalence of AF was higher in men (4.3%) than in women (1.9%). Men had a worse cardiovascular risk factor profile, a higher prevalence of cardiovascular disease, but fewer symptoms than women. Age-a…

AdultMalemedicine.medical_specialtyCross-sectional studyHeart VentriclesPopulation030204 cardiovascular system & hematologyRisk AssessmentVentricular Function LeftCoronary artery diseaseElectrocardiography03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsGermanyInternal medicineAtrial FibrillationPrevalenceHumansMedicine030212 general & internal medicineMyocardial infarctionRisk factoreducationAgedRetrospective Studieseducation.field_of_studybusiness.industryIncidenceRetrospective cohort studyAtrial fibrillationOdds ratioMiddle Agedmedicine.disease3. Good healthSurvival RateCross-Sectional StudiesEchocardiographyPopulation SurveillanceCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011:current status in 37 ESC countries

2014

Item does not contain fulltext AIMS: Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. METHODS AND RESULTS: A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, dat…

AdultMalemedicine.medical_specialtyCross-sectional studymedicine.medical_treatmentVascular damage Radboud Institute for Health Sciences [Radboudumc 16]PopulationCardiologyMyocardial Infarctionacute myocardial infarction610 Medicine & healthMyocardial ReperfusionPercutaneous Coronary InterventionReperfusion therapyHumansMedicineThrombolytic TherapyIn patientHospital MortalityRegistriescardiovascular diseasesMyocardial infarctioneducationAgededucation.field_of_studybusiness.industryST elevationCoronary Care UnitsPercutaneous coronary interventionThrombolysisMiddle Agedmedicine.disease3. Good healthEuropeCross-Sectional Studiessurgical procedures operativeEmergency medicineWorkforceFemaleHuman medicineMedical emergencyCardiology and Cardiovascular Medicinebusiness
researchProduct

The impact of coexistent diabetes on the prevalence of coronary heart disease.

1997

Abstract The increased risk of developing cardiovascular disease in diabetic population has been well documented, but the prevalent mechanism of this susceptibility is still only partly explained. We compared the impact of diabetes on ischemic heart disease in patients hospitalized in a public general hospital over a 10-year period. The prevalence of coronary heart disease (CHD) was consistently higher among diabetic population [namely, among non-insulin-dependent diabetes mellitus (NIDDM) patients] when compared with the nondiabetic population. The prevalence was similar in both genders, increasing with age, and was independent from body-mass index, history of smoking, metabolic control, o…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationCoronary DiseaseDiseaseMedical RecordsImpaired glucose toleranceEndocrinologyAge DistributionInternal medicineDiabetes mellitusGlucose IntoleranceInternal MedicinemedicinePrevalenceHumansRisk factoreducationAgedRetrospective Studieseducation.field_of_studyFramingham Risk Scorebusiness.industryVascular diseaseMiddle Agedmedicine.diseaseBlood pressureEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2ItalyCardiologyFemalebusinessDiabetic AngiopathiesJournal of diabetes and its complications
researchProduct

Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.

2005

Background Monocyte chemoattractant protein-1 (MCP-1) is involved in the recruitment of monocytes into the arterial vessel wall as one of the major events leading to atherosclerotic vascular diseases, such as coronary artery disease (CAD). Methods and Results The study group comprised 263 volunteers aged between 18 and 85 years who were admitted to hospital or clinic for scheduled invasive and non-invasive diagnostic procedures. MCP-1 serum levels were determined using a sandwich-enzyme-linked immunosorbent assay. In each patient, the coronary risk factors (CRF), such as hypertension, high cholesterol, diabetes mellitus, obesity, positive family history, and smoking were evaluated. Low-dens…

AdultMalemedicine.medical_specialtyEndotheliumAdolescentEnzyme-Linked Immunosorbent AssayCoronary Artery DiseaseCoronary AngiographyHigh cholesterolCoronary artery diseaseEndothelial activationRisk FactorsInternal medicineDiabetes mellitusMedicineHumansChemokine CCL2Agedbusiness.industryGeneral MedicineMiddle AgedIntercellular adhesion moleculemedicine.diseaseAtherosclerosismedicine.anatomical_structureCardiologyFemaleEndothelium VascularCardiology and Cardiovascular MedicinebusinessBiomarkersArteryLipoproteinCirculation journal : official journal of the Japanese Circulation Society
researchProduct

White-coat hypertension and cardiovascular risk

1995

OBJECTIVE: To compare cardiovascular risk in white-coat hypertensives, normotensives and established hypertensives. METHODS: We studied 61 hypertensive individuals, 27 of whom were white-coat hypertensives, and 35 normotensives. All subjects underwent 24 h noninvasive blood pressure monitoring and Doppler echocardiographic examination of the heart; urine was tested for microalbuminuria and the fundi of the eyes examined for retinopathy. RESULTS: The 24 h as well as the day- and night-time mean systolic blood pressure (SBP) was slightly but significantly higher in white-coat hypertensives than in normotensives; no significant difference was observed in diastolic blood pressure (DBP) between …

AdultMalemedicine.medical_specialtyEpidemiologyWhite coat hypertensionCoronary DiseaseUrineLower riskVentricular Function LeftRisk FactorsInternal medicineMedicineAlbuminuriaHumansPhysician-Patient RelationsEjection fractionbusiness.industryMiddle Agedmedicine.diseaseBlood pressureCross-Sectional StudiesEchocardiographyHypertensionCardiologyAlbuminuriaMicroalbuminuriaFemalemedicine.symptombusinessCardiology and Cardiovascular MedicineStress PsychologicalRetinopathy
researchProduct